Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jun 07, 2024

BUY
$16.14 - $23.55 $1.59 Million - $2.33 Million
98,762 New
98,762 $2.29 Million
Q4 2022

Feb 13, 2023

BUY
$16.14 - $23.55 $1.59 Million - $2.33 Million
98,762 New
98,762 $2.29 Million

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.12B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Sg Capital Management LLC Portfolio

Follow Sg Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Capital Management LLC with notifications on news.